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Effects of Scutellarin on MUC5AC Mucin Production Induced by 
Human Neutrophil Elastase or Interleukin 13 on Airway 
Epithelial Cells
Scutellarin is a flavonoid extracted from a traditional Chinese herb, Erigeron breviscapus. 
The present study investigated the effect of scutellarin on MUC5AC mucin production and 
the possible mechanism. Human bronchial epithelial 16 (HBE16) cells were pretreated with 
scutellarin for 60 min, and then exposed to human neutrophil elastase (HNE) or interleukin 
(IL)-13 for 12 hr. RT-PCR and ELISA were performed to measure the amount of MUC5AC 
mucin production. The results showed that scutellarin inhibited MUC5AC expression both 
in mRNA and protein level induced by HNE in a concentration-dependent manner. 
However, scutellarin failed to inhibit MUC5AC mucin production induced by IL-13. To 
investigate the intracellular mechanisms associated with the effect of scutellarin on 
MUC5AC mucin production, western blotting was carried out to examine the 
phosphorylation of protein kinase C (PKC), signal transducer and activator of transcription 
6 (STAT6) and extracellular signal-regulated kinase 1/2 (ERK1/2). The phosphorylation of 
PKC and ERK1/2 was attenuated after treatment with scutellarin, whereas STAT6 was not 
significantly affected. Therefore, it is suggested that scutellarin down-regulates MUC5AC 
mucin production on HBE16 cells via ERK-dependent and PKC-dependent pathways.
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ORIGINAL ARTICLE
Respiratory Diseases
INTRODUCTION 
The excess mucus production is an important feature of chron-
ic inflammatory diseases, including chronic bronchitis, bron-
chiectasis and asthma. Mucus overproduction contributes to 
morbidity and mortality in many patients, particularly in those 
with more severe disease. During acute exacerbation of chronic 
obstructive pulmonary disease (COPD), human neutrophil elas-
tase (HNE), reactive oxygen species (ROS) and many cytokines 
may injure the airway and activate mucin gene regulation (1). 
Excessive mucus in the airways is linked to an increase in the 
frequency and duration of infection and a decline in lung func-
tion. More than 20 human mucin genes have been deposited   
in the GenBank. Among all these mucin in mammals, mucin 
(MUC) 5AC and MUC5B are produced significantly in intrapul-
monary airways. Up-regulated MUC5AC expression is the cen-
tral event in goblet cell metaplasia (2). HNE has been shown to 
be a potent secretagogue for goblet cells in vitro and in vivo. HNE 
increases the transcriptional activity of MUC5AC promoter and 
MUC5AC mRNA expression through mitogen-activated pro-
tein kinase (MAPK)/extracellular signal-regulated kinase (ERK) 
signaling pathways. HNE is also known to elevate the MUC5AC 
mRNA levels by enhancing mRNA stability or inducing ROS (3, 
4). Several cytokines including tumor necrosis factor, interleukin 
(IL)-1β, and IL-13 upregulate MUC5AC expression. IL-13, a cen-
tral mediator of airway remodeling in asthma, increases MUC5AC 
expression by the phosphorylation of signal transducer and ac-
tivator of transcription 6 (STAT6) and the suppression of the 
transcription factor, Forkhead boxA2 (FOXA2) (5). 
  Mucoregulatory medications decrease mucin secretion or 
impede the formation of the DNA/F-actin secondary polymer 
network. The most thoroughly studied mucoregulatory medi-
cations are the low-dose macrolide antibiotics. The mechanism 
of that medication appears to be through the modulation of the 
MAPK/ERK cascade (6). However, rapid spread of bacterial re-
sistance has been observed after overdose medication or the 
inaccurate treatment. Moreover, the gastrointestinal adverse 
events of macrolide antibiotics occurred frequently, including 
gastroesophageal reflux and functional dyspepsia. All these prob-
lems have impeded the application of the macrolide antibiotic 
as an effective treatment for mucus hypersecretion. No current 
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in clinical management of patients with COPD or asthma. In 
these clinical situations, it is noteworthy to find novel therapeu-
tic approaches to decrease mucus hypersecretion. 
  It was reported that several natural compounds such as genis-
tein and curcumin could affect mucus production in the airway. 
Ram and his colleagues reported that curcumin attenuated al-
lergen induced airway hyperresponsiveness in sensitized guin-
ea pigs (7). Also, Heo and his colleagues (8) reported that genis-
tein and curcumin suppressed epidermal growth factor induced 
MUC5AC mucin production and gene expression from human 
airway epithelial cells. Thus, natural compounds might provide 
possible approaches to prevent mucus hypersecretion.
  Scutellarin (scu) (Fig. 1), a known flavone 7-O-β-D-glucuro-
nide with a molecular weight of 462.21, is considered as the pri-
mary active ingredient of breviscapine. It has been extensively 
used to treat ischemic cerebrovascular and cardiovascular dis-
eases (9, 10). Scutellarin has been observed to possess compre-
hensive pharmacological functions, including dilating vessels, 
inhibiting platelet aggregation and reducing intracellular free 
Ca
2+ levels (11). Nowadays, various preparations of scutellarin 
are still widely used clinically to treat cerebrovascular and car-
diovascular diseases such as hypertension, angina pectoris, cor-
onary heart disease, cerebral ischemia and vascular dementia. 
Scutellarin also possesses strong ability to inhibit protein kinase 
C (PKC) (12, 13), which is involved in the regulation of MUC5AC 
expression in vivo and in vitro (14, 15). Therefore, we hypothe-
size that scutellarin may decrease MUC5AC mucin production 
in airway epithelial cells. 
  In this study, the immortalized human bronchial epithelial 
cell line (HBE-16) were pretreated with scutellarin for 60 min 
and then exposed to HNE or IL-13 for 12 hr. MUC5AC mucin 
product was assessed by RT-PCR and ELISA. We investigated 
intracellular mechanisms and signaling pathways associated 
with the effects of scutellarin on MUC5AC mucin production. 
The mechanism appears to involve the inhibition of PKC and 
ERK1/2.
MATERIALS AND METHODS
Materials
All the antibodies were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA) unless otherwise specified. All the 
chemicals and reagents were from Sigma (St. Louis, MO, USA) 
unless otherwise indicated. Calphostin C (a specific PKC inhibi-
tor) and PD98059 (a specific ERK inhibitor) were purchased from 
Calbiochem (San Diego, CA, USA). A771726 were purchased 
from Enzo Life Sciences. The HNE inhibitor elastatinal was ob-
tained from Calbiochem (La Jolla, CA, USA). Scutellarin (purity 
> 95%) was purchased from Wangzilong Pharmaceutical Co. 
LTD (Yuxi, Yunnan, China). Scutellarin was dissolved in DMSO 
and diluted with saline before use. The final concentration of 
DMSO was less than 0.1%. 
Normal human bronchial epithelial cell culture 
HBE-16 cells were maintained in RPMI-1640 medium (Gibco-
Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal 
calf serum (Gibco) and 1% weight per volume penicillin/strep-
tomycin (Gibco). Cell cultures were maintained in a humidified 
atmosphere of 5% CO2 in air at 37°C. The medium was changed 
till cells were 90% confluent.  
Exposure of the cells to HNE or IL-13 
The cells were seeded in 6-well plate at 5 × 10
5 cells/well. After 
the cells reached 90% confluence, they were serum starved for 
24 hr to maintain a low basal level of MUC5AC mucin produc-
tion. To determine the effects of HNE (Elastin Products, Owens-
ville, MO, USA) or IL-13 (Peprotech, Hill, NJ, USA), cells were 
exposed to 0.01-1 μM/L HNE or 1-25 ng/mL recombinant hu-
man IL-13 for 12 hr (15, 16). 
Treatment with scutellarin 
To investigate the concentration effect of scutellarin on the cell, 
the cells were incubated in RPMI-1640 medium containing scu-
tellarin with the concentration from 10 μM/L to 100 μM/L for 
60 min (17) and then exposed to 0.1 μM/L HNE or 10 ng/mL re-
combinant human IL-13 for 12 hr. In the positive control group, 
Elastatinal (100 μM/L) was added to the medium before expo-
sure to HNE and A771726 (10 μM/L) was used as an inhibitor 
against IL-13. In the negative control group, the cells were incu-
bated with medium alone. At the end of stimulation, cells were 
collected for further evaluations.
 
RT-PCR
Total RNA was extracted from HBE16 cells after stimulation with 
HNE or IL-13 for 12 hr using ISOGEN (Gibco-Invitrogen). Oli-
gonucleotide primers for PCR were designed according to the 
published sequence for human MUC5AC (sense: TCA ACG 
GAG ACT GCG AGT ACA C; antisense: TCT TGA TGG CCT TGG 
AGC A). The PCR conditions were as follows: a pre-denaturing 
at 94°C for 10 min, followed by 33 cycles of denaturation at 94°C 
for 30 sec, annealing at 59°C for 30 sec and extension at 72°C for 
30 sec. PCR products were separated by electrophoresis through 
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1% agarose gel containing ethidium bromide, and the signal in-
tensity was analyzed by BIO-RAD Image. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) controls were used to stan-
dardize the quantification of RNA samples. 
ELISA
The MUC5AC protein was measured by enzyme-linked immu-
nosorbent assay (ELISA). The cells were lysed in a standard RIPA 
buffer, containing protease inhibitors. All the samples were in-
cubated at 42°C in a 96-well plate for 1 hr and 4°C overnight. The 
plates were washed three times with PBS and blocked with 2% 
BSA for 1 hr at room temperature. After washing the plates for 
three times with PBS, the wells were incubated in PBS with mouse 
monoclonal antibody against MUC5AC (NeoMarkers, Fremont, 
CA, USA) for 1 hr, which was diluted with PBS containing 0.05% 
Tween 20. Then, the wells were washed three times with PBS, 
and 100 μM of horseradish peroxidase-goat anti-mouse IgG 
conjugate was dispensed into each well for 1 hr. The plates were 
washed three times with PBS and the color reaction was devel-
oped with 3, 3’ , 5, 5’-tetramethylbenzidine peroxide solution and 
stopped with 50 mM/L H2SO4. The absorbance was read at 405 
nm wavelengths using a synergy HT multi-detection microplate 
reader. 
Western blot analysis
The phosphorylation PKC, ERK1/2 and STAT6 were examined 
by western analysis. Cells were collected at the end of exposure. 
Protein concentrations were determined by Bio-Rad assays. Cells 
lysate was fractionated on SDS–PAGE, and proteins were then 
transferred to a nitrocellulose membrane (Millipore, Billerica, 
MA, USA). Membranes were blocked with 5% FBS in Tris-buff-
ered saline containing 0.1% Tween 20 at room temperature for 
1 hr and then incubated overnight at 4°C with the mouse anti-
bodies against p-PKC, p-ERK1/2 and p-STAT6. GAPDH protein 
was used to normalize the total tissue lysate on the same nitro-
cellulose membrane. After three washed, membranes were in-
cubated for 1 hr at room temperature with horseradish peroxi-
dase conjugate goat anti-mouse IgG antibody. The three washes 
were repeated, and then protein was visualized with enhanced 
chemiluminescence kit (Amersham Pharmacia Biotech, Pisca-
taway, NJ, USA). 
Statistical analysis
The results were expressed as mean ± SEM. Differences were 
examined for statistical significance using one-way analysis of 
variance. The post hoc test was Fisher’s protected least signifi-
cant difference (PLSD) test. A P value < 0.05 denoted the pres-
ence of a statistically significant difference. 
RESULTS
Effects of HNE or IL-13 on MUC5AC gene and protein 
expression 
To confirm whether HNE or IL-13 can induce MUC5AC mucin 
production on HBE-16 cells, we first evaluated the MUC5AC 
protein expression after addition of HNE or IL-13 to the cells at 
various concentrations. We found that the stimulation with HNE 
led to a concentration-dependent increase in MUC5AC produc-
tion compared with the control group (Fig. 2). The expression 
of MUC5AC protein also increased as a result of IL-13 stimula-
tion in a concentration dependent manner (Fig. 3). 
Scutellarin inhibited MUC5AC mucin production induced 
by HNE 
We next evaluated the effects of scutellarin on MUC5AC expres-
sion induced by HNE. RT-PCR and ELISA were used to examine 
the expression of MUC5AC production regulated by scutellarin. 
The cells were pretreated with scutellarin for 60 min before the 
addition of 0.1 μM/L NHE. In the HNE control group, the cells 
were stimulated with HNE after treatment with medium only. 
As shown in Fig. 4, scutellarin significantly reduced the enhanc-
ed expression of MUC5AC induced by HNE at both the mRNA 
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Fig. 2. Up-regulation of MUC5AC protein induced by human neutrophil elastase (HNE) 
on HBE16 cells. Cells were collected after exposed to HNE at different concentrations. 
The amount of MUC5AC was measured by ELISA. Data represent means ± SEM of 
four experiments. ﹡P < 0.05 compared with the negative control group. 
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Fig. 3. Up-regulation of MUC5AC induced by IL-13 on HBE16 cells. Cells were collect-
ed after exposed to IL-13 at different concentrations. The amount of MUC5AC was 
measured by ELISA. Data represent means ± SEM of four experiments. ﹡P < 0.05 
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and protein levels. In the positive control group, elastatinal great-
ly reduced the MUC5AC synthesis induced by HNE (data not 
shown). 
  The mRNA and protein expression of MUC5AC decreased as 
a result of scutellarin inhibition in a concentration dependent 
manner. Half-maximal inhibition effect was elicited after incu-
bation with scutellarin at the concentration of 50 μM/L (Fig. 4B). 
Therefore, concentration of 50 μM/L was chosen for the follow-
ing experiments.
Scutellarin did not reduce MUC5AC mucin production 
induced by IL-13 
To determine whether scutellarin could inhibit mucus produc-
tion induced by IL-13, MUC5AC synthesis was assayed using 
RT-PCR and ELISA. The cells were pretreated with scutellarin 
for 60 min before the addition of 10 ng/mL IL-13. In the IL-13 
control group, the cells were stimulated with IL-13 after treat-
ment with medium only. As shown in Fig. 5, scutellarin did not 
reduce the MUC5AC synthesis induced by IL-13 at both the 
mRNA and protein levels.
Scutellarin inhibited PKC signaling responding to HNE 
stimuli
We investigated the possible involvement of PKC in the protec-
tive activity of scutellarin against mucus secretion. The cells were 
preincubated with 0.1 μM/L calphostin C or 50 μM/L scutellarin 
for 60 min before exposed to 0.1 μM/L HNE for 1 hr. As shown 
in Fig. 6, PKC activity induced by HNE was attenuated when the 
cells were pretreated with calphostin C. Compared with the HNE 
control group, a significant decrease in the phosphorylation of 
PKC was also observed when the cells were pretreated with scu-
tellarin.
The phosphorylation of ERK1/2 and STAT6 after treatment 
with scutellarin 
To study the involvement of ERK1/2 in the protective activity of 
scutellarin against MUC5AC mucin production induced by HNE, 
the cells were stimulated with HNE for 1 hr after treatment with 
50 μM/L scutellarin or 50 μM/L PD98059 for 60 min. As shown 
in Fig. 7, Pretreatment with PD98059 resulted in significant de-
creases in ERK1/2 phosporylation when exposed to HNE. Com-
Fig. 4. Effects of scutellarin (scu) on MUC5AC mRNA (A) and protein (B) expression 
after exposed to HNE. The cells were pretreated with scu or medium only for 60 min 
before the addition of 0.1 µM/L HNE. Total RNAs were reverse transcribed and used 
for PCR amplication (A). The amount of MUC5AC protein was measured by ELISA (B). 
Data represent means ± SEM of four experiments. ﹡P < 0.05 compared with the 
negative group; 
†P < 0.05 compared with the HNE control group.
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before the addition of 10 ng/mL IL-13. Total RNAs were reverse transcribed and used 
for PCR amplication (A). The amount of MUC5AC protein was measured by ELISA (B). 
Data represent means ± SEM of four experiments. ﹡P < 0.05 compared with the 
negative control group; 
‡P > 0.05 compared with the IL-13 control group. 
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pared with the HNE control group, the phosphorylation of ERK1/ 
2 also significantly decreased after treatment with scutellarin. 
  For STAT6 group, the cells were pretreated with 50 μM/L scu-
tellarin or 10 μM/L A771726 for 60 min before exposed to 10 ng/ 
L IL-13 for 1 hr. As shown in Fig. 8, A771726 significantly decreas-
es STAT6 phosphorylation responding to IL-13. In contrast, pre-
treatment with scutellarin failed to interrupt STAT6 phosphory-
lation when exposed to IL-13. These data suggest that MAPK/
ERK signal pathway, not STAT6 pathway, may play an important 
role in the inhibition of scutellarin on MUC5AC mucin produc-
tion induced by HNE. 
DISCUSSION 
Excessive mucus secretion is problematic in patients with chron-
ic airway diseases due to airway obstruction and impairment  
of gas exchange. In this study, we carried out experiments to 
examine whether treatment with scutellarin might attenuate 
mucus production induced by HNE or IL-13. Our study dem-
onstrated that: 1) stimulation with HNE or IL-13 increased the 
expression of MUC5AC; 2) scutellarin significantly attenuated 
the MUC5AC expression at both the mRNA and protein levels 
induced by HNE. However, scutellarin failed to inhibit the MU-
C5AC expression induced by IL-13; 3) PKC played an important 
role in mucus secretion and was involved in the inhibition of 
scutellarin against MUC5AC mucin production induced by 
HNE; 4) MAPK/ERK, but not STAT6 pathway, was implicated in 
the effects of scutellarin on mucus production. 
  Our study demonstrated that HNE and IL-13 induced MU-
C5AC expression on HBE-16 cells. HNE is the most widely stud-
ied with regard to enhanced mucus secretion. Purified HNE has 
been shown to provoke secretion of mucin by isolated airway 
epithelial cells and glands from several species (3, 4, 15). Mucin 
protein is also upregulated by IL-13, which plays a central role 
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in the pathogenesis of chronic inflammatory diseases. Previous 
studies have indicated that IL-13 could induce mucus secretion 
in mouse airways via the expression of both the IL-13 receptor 
and the IL-13 signaling molecule signal transducer (18). Up-
regulated signaling through STAT6 pathway plays an important 
role in mucus production induced by IL-13 (5, 16). 
  After the confirmation of the effect of HNE or IL-13 on mucus 
secretion on HBE16 cells, we investigate the effect of scutellarin 
on MUC5AC mucin production induced by HNE or IL-13. Com-
pared with calphostin C, scutellarin showed an equipotent ef-
fect in the inhibition of MUC5AC mucin production induced by 
HNE. However pretreatment with scutellarin did not reduce IL-
13 induced MUC5AC production. To investigate the reason for 
this discrepancy with the effect of scutellarin against MUC5AC 
production induced by HNE or IL-13, we examined the effects 
of scutellarin on MAPK/ERK signaling transduction and STAT6 Jiang D-P, et al.  •  Effects of Scutellarin on MUC5AC Mucin Production
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signal transduction. Scutellarin attenuated the phosphorylation 
of ERK1/2, which was significantly phosphorylated after the 
stimulation of HNE. Pretreatment with scutellarin failed to at-
tenuate the phosphorylation of STAT6 induced by IL-13. In con-
trast, A771726, a specific STAT6 inhibitor, greatly decreased the 
phosphorylation of STAT6 and the expression of MUC5AC in-
duced by IL-13. Taken together, we identified that scutellarin 
down-regulated MUC5AC production induced by HNE through 
MAPK/ERK signal transduction. Scutellarin could not affect 
mucus production induced by IL-13 and STAT6 pathway was 
not involved in the mechanism of scutellarin on MUC5AC pro-
duction. 
  Among a variety of signal transduction molecules, MAPK has 
been shown to play an important role in mucus secretion (19). 
Kuwahara demonstrated that a PKC → ERK1/2 → Sp1 pathway 
was responsible for HNE-activated mucus secretion (20). Our 
study showed that such pathway might be related to the protec-
tive effect of scutellarin against MUC5AC production. Pan et al. 
(11) reported that suppression of ERK1/2 activation by scutella-
rin represented one of the possible mechanisms accounting for 
its beneficial effects on impaired cardiac function after myocar-
dial infarction. Our results are consistent with the conclusion 
and clearly reveal that scutellarin blocked ERK pathway activat-
ed by HNE.
  PKC was known to be involved in secretion of airway mucin 
responding to various stimuli (14). It has been reported that scu-
tellarin has the strong inhibitory effects on PKC activation, which 
contributes to its protective role in cerebral ischemia and hepat-
ic injury during brain-death (12, 13). To confirm whether PKC 
was involved in the inhibition of scutellarin against mucus pro-
duction on HBE16, phosphorylation of PKC was determined  
by western blotting. Our data clearly revealed that scutellarin 
blocked PKC activation induced by HNE. Inhibition of PKC at-
tenuated HNE-mediated mucus secretion. Therefore, the effect 
of scutellarin on MUC5AC mucin production can be part as-
cribed to its specifically blocking PKC activation. 
  The mechanism whereby scutellarin inhibit PKC is uncer-
tain. Many studies have shown that scutellarin is a Ca
2+ chan-
nel-blocking agent with the ability to inhibit extracellular calci-
um influx (11, 21). Pan et al. (22) reported scutellarin exerted its 
anti-hypertrophic effects via suppressing the Ca
2+-mediated 
calcineurin. Hong et al. (23) reported that scutellarin protected 
against hydrogen peroxide-induced cytotoxicity in PC12 cells 
via reducing intracellular accumulation of Ca
2+. Considering 
calcium as a robust activator of PKC, the inhibition of scutellar-
in on PKC phosphorylation might be associated with its ability 
to block Ca
2+ channel. Interestingly, correlation between calci-
um channels and mucus expression in airways has suggested a 
causal relationship. Transfection of hCLCA1 into human mu-
coepidermoid cells resulted in up-regulation of the MUC5AC 
gene (24). Macrolide antibiotics, the most thoroughly studied 
mucoregulatory medications, may inhibit mucus secretion via 
reducing intracellular accumulation of Ca
2+ (25). Therefore, the 
molecular mechanism of scutellarin against mucus secretion 
might be associated with its ability to block calcium channel. 
Further studies are required to investigate the specific mecha-
nism. 
  In conclusion, the present study has demonstrated that scu-
tellarin inhibited MUC5AC mucin production via inhibiting 
PKC activation and diminishing the phosphorylation of ERK1/2. 
Our results provide experimental evidence for the use of scutel-
larin in the clinic as effective means for treatment of mucus hy-
persecretion. Indeed, scutellarin shows promising effect on re-
spiratory disease and possesses wide-ranging positive effects on 
the control of mucus secretion. Importantly, the curative dosage 
of scutellarin in clinic is safe, without liver or kidney toxicity. It 
has been used in cardiovascular disease and cerebral infarction 
with satisfactory tolerance and safety (26). In addition to this, it 
is supposed that scutellarin is a potential effective and safety 
candidate in the regulation of mucus secretion. 
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Mucus hypersecretion is clinically critical problem of various airway diseases. The present study demonstrates that scutellarin 
inhibited MUC5AC mucin production via inhibiting PKC activation and diminishing the phosphorylation of ERK1/2. Our results 
provide experimental evidence for a plausibility of clinical trial of scutellarin treatment for the mucus hypersecretion. Our results 
suggest that the clinically applicable dosage of scutellarin could be safe, without liver or kidney toxicity. As a whole, we suppose 
that scutellarin is a potentially effective and safety candidate in the regulation of mucus secretion.